RxDoctor Payments Data

Sarah Golden, APRN

Psychiatric/Mental Health · Nashville, TNNPI 1912649005

Payments from drug & device makers

$4,536in general payments, 2019–2025

Across 219 payments — averaging $20.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$664
  • Alkermes, Inc.$569
  • Neurocrine Biosciences, Inc.$454
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$371
  • Axsome Therapeutics, Inc.$321
  • Otsuka America Pharmaceutical, Inc.$270
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$4,527100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,536 in reported general payments places this provider in the 85th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$7,359
Medicare patients
22
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate19$1,887
Bupropion XlBupropion Hcl30$1,252
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine15$1,076
Trazodone Hcl40$584
Venlafaxine Hcl ErVenlafaxine Hcl21$486
Clonazepam41$440
Lamotrigine22$360
Lorazepam40$295
Duloxetine Hcl17$278
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine14$268
Escitalopram Oxalate18$242
Buspirone Hcl17$175
Alprazolam41$158
Quetiapine Fumarate19$155
Zolpidem Tartrate57$143

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →